21 firms ranked by verified Biotech deal count, led by Alexandria Venture Investments, ARCH Venture Partners.
Biotech accounts for 120 tracked companies with verified cap-table data, 120 of which disclose round sizes totalling $58B. The median disclosed raise is $279M, and the largest is Metsera at $10B, ahead of Revolution Medicines ($2.1B) and Kailera Therapeutics ($1.6B).
The names that recur most often on these biotech cap tables are ARCH Venture Partners (14 companies), RA Capital Management (14 companies), OrbiMed (13 companies), Foresite Capital (12 companies), Atlas Venture (10 companies), Fidelity Management & Research Company (9 companies). By latest disclosed round, the market skews Series B (26), Series A (20), Series C (18), Series D (18).
Companies tracked: 120
Disclosed funding total: $58B across 120 companies
Median disclosed raise: $279M
Largest raise: Metsera — $10B
Stage mix: Series B 26 · Series A 20 · Series C 18 · Series D 18
